Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Qol and Patients' Care

Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients

Bone Marrow Transplantation volume 50, pages 1235–1240 (2015)Cite this article

Subjects

Abstract

Quality of life (QOL) is an important outcome for hematopoietic cell transplantation (HCT) recipients. Whether pre-HCT QOL adds prognostic information to patient and disease related risk factors has not been well described. We investigated the association of pre-HCT QOL with relapse, non-relapse mortality (NRM), and overall mortality after allogeneic HCT. From 2003 to 2012, the Functional Assessment of Cancer Therapy-Bone Marrow Transplant Scale instrument was administered before transplantation to 409 first allogeneic HCT recipients. We examined the association of the three outcomes with (1) individual QOL domains, (2) trial outcome index (TOI) and (3) total score. In multivariable models with individual domains, functional well-being (hazard ratio (HR) 0.95, P=0.025) and additional concerns (HR 1.39, P=0.002) were associated with reduced risk of relapse, no domain was associated with NRM, and better physical well-being was associated with reduced risk of overall mortality (HR 0.97, P=0.04). TOI was not associated with relapse or NRM but was associated with reduced risk of overall mortality (HR 0.93, P=0.05). Total score was not associated with any of the three outcomes. HCT-comorbidity index score was prognostic for greater risk of relapse and mortality but not NRM. QOL assessments, particularly physical functioning and functional well-being, may provide independent prognostic information beyond standard clinical measures in allogeneic HCT recipients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gotay CC, Kawamoto CT, Bottomley A, Efficace F . The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 2008; 26: 1355–1363.

    Article  Google Scholar 

  2. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR . Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 2001; 31: 233–240.

    Article  CAS  Google Scholar 

  3. Dharma-Wardene M, Au HJ, Hanson J, Dupere D, Hewitt J, Feeny D . Baseline FACT-G score is a predictor of survival for advanced lung cancer. Qual Life Res 2004; 13: 1209–1216.

    Article  CAS  Google Scholar 

  4. Li TC, Li CI, Tseng CH, Lin KS, Yang SY, Chen CY et al. Quality of life predicts survival in patients with non-small cell lung cancer. BMC Public Health 2012; 12: 790.

    Article  Google Scholar 

  5. Staren ED, Gupta D, Braun DP . The prognostic role of quality of life assessment in breast cancer. Breast J 2011; 17: 571–578.

    Article  Google Scholar 

  6. Braun DP, Gupta D, Staren ED . Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer 2011; 11: 353.

    Article  Google Scholar 

  7. Braun DP, Gupta D, Staren ED . Predicting survival in prostate cancer: the role of quality of life assessment. Support Care Cancer 2012; 20: 1267–1274.

    Article  Google Scholar 

  8. Cella D, Cappelleri JC, Bushmakin A, Charbonneau C, Li JZ, Kim ST et al. Quality of life predicts progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib versus interferon alfa. J Oncol Pract 2009; 5: 66–70.

    Article  Google Scholar 

  9. Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY . Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys 2004; 58: 1394–1404.

    Article  Google Scholar 

  10. Fang FM, Liu YT, Tang Y, Wang CJ, Ko SF . Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 2004; 100: 425–432.

    Article  Google Scholar 

  11. Roychowdhury DF, Hayden A, Liepa AM . Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. J Clin Oncol 2003; 21: 673–678.

    Article  CAS  Google Scholar 

  12. Monk BJ, Huang HQ, Cella D, Long HJ III, Gynecologic Oncology Group S. Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group Study. J Clin Oncol 2005; 23: 4617–4625.

    Article  CAS  Google Scholar 

  13. Bevans MF, Marden S, Leidy NK, Soeken K, Cusack G, Rivera P et al. Health-related quality of life in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38: 101–109.

    Article  CAS  Google Scholar 

  14. Brandt J, Dietrich S, Meissner J, Neben K, Ho AD, Witzens-Harig M . Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy. Leuk Lymphoma 2010; 51: 2012–2020.

    Article  CAS  Google Scholar 

  15. Bush NE, Donaldson GW, Haberman MH, Dacanay R, Sullivan KM . Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant 2000; 6: 576–591.

    Article  CAS  Google Scholar 

  16. Chao NJ, Tierney DK, Bloom JR, Long GD, Barr TA, Stallbaum BA et al. Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood 1992; 80: 825–830.

    CAS  PubMed  Google Scholar 

  17. La Nasa G, Caocci G, Efficace F, Dessi C, Vacca A, Piras E et al. Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia. Blood 2013; 122: 2262–2270.

    Article  CAS  Google Scholar 

  18. Sanders J, Sullivan K, Witherspoon R, Doney K, Anasetti C, Beatty P et al. Long term effects and quality of life in children and adults after marrow transplantation. Bone Marrow Transplant 1989; 4 (Suppl 4): 27–29.

    PubMed  Google Scholar 

  19. Pidala J, Anasetti C, Jim H . Quality of life after allogeneic hematopoietic cell transplantation. Blood 2009; 114: 7–19.

    Article  CAS  Google Scholar 

  20. Hamilton BK, Rybicki L, Dabney J, McLellan L, Haddad H, Foster L et al. Quality of life and outcomes in patients >60 years of age after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2014; 49: 1426–1431.

    Article  CAS  Google Scholar 

  21. McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19: 357–368.

    Article  CAS  Google Scholar 

  22. Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant 2009; 15: 367–369.

    Article  Google Scholar 

  23. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912–2919.

    Article  CAS  Google Scholar 

  24. Bolwell B, Sobecks R, Pohlman B, Andresen S, Rybicki L, Kuczkowski E et al. A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant 2004; 34: 621–625.

    Article  CAS  Google Scholar 

  25. Hamadani M, Craig M, Awan FT, Devine SM . How we approach patient evaluation for hematopoietic stem cell transplantation. Bone Marrow Transplant 2010; 45: 1259–1268.

    Article  CAS  Google Scholar 

  26. Sorror ML . Comorbidities and hematopoietic cell transplantation outcomes. Hematology Am Soc Hematol Educ Program 2010; 2010: 237–247.

    Article  Google Scholar 

  27. Montazeri A . Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 2009; 7: 102.

    Article  Google Scholar 

  28. Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 2009; 10: 865–871.

    Article  Google Scholar 

  29. Quinten C, Martinelli F, Coens C, Sprangers MA, Ringash J, Gotay C et al. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer 2014; 120: 302–311.

    Article  Google Scholar 

  30. Majhail NS, Brunstein CG, McAvoy S, DeFor TE, Al-Hazzouri A, Setubal D et al. Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants. Biol Blood Marrow Transplant 2008; 14: 985–992.

    Article  CAS  Google Scholar 

  31. Nakaya A, Mori T, Tanaka M, Tomita N, Nakaseko C, Yano S et al. Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy. Biol Blood Marrow Transplant 2014; 20: 1553–1559.

    Article  Google Scholar 

  32. Foster LW, McLellan L, Rybicki L, Dabney J, Copelan E, Bolwell B . Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study. Bone Marrow Transplant 2013; 48: 671–677.

    Article  CAS  Google Scholar 

  33. Wood WAL-R, Fei J, Logan M, Syrjala B, Majhail K, Wingard N et al. Patient-reported quality of life is an independent predictor of survival after allogeneic hematopoietic cell transplantation: a secondary analysis from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. Blood 2014; 124: Abstract 206.

Download references

Author information

Authors and Affiliations

  1. Taussig Cancer Institute, Blood & Marrow Transplant Program, Cleveland Clinic, Cleveland, OH, USA

    B K Hamilton, A D Law, D Abounader, J Dabney, R Dean, H K Duong, A T Gerds, R Hanna, B T Hill, D Jagadeesh, M E Kalaycio, C Lawrence, L McLellan, B Pohlman, R M Sobecks, B J Bolwell & N S Majhail

  2. Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA

    L Rybicki

Authors
  1. B K Hamilton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A D Law
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L Rybicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Abounader
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Dabney
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R Dean
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H K Duong
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A T Gerds
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R Hanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. B T Hill
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. D Jagadeesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. M E Kalaycio
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. C Lawrence
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. L McLellan
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. B Pohlman
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. R M Sobecks
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. B J Bolwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. N S Majhail
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N S Majhail.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on Bone Marrow Transplantation website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hamilton, B., Law, A., Rybicki, L. et al. Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients. Bone Marrow Transplant 50, 1235–1240 (2015). https://doi.org/10.1038/bmt.2015.122

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2015.122

This article is cited by

Search

Advanced search

Quick links